Skip to main content

Windtree Therapeutics Inc (WINT)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.00
As of

Kresmion compiles this page from WINT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

WINDTREE THERAPEUTICS INC /DE/ (WINT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-22.

As of . Source: SEC EDGAR filings for WINT. Method and limitations.

COMPANY DOSSIER

See the full WINT dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for WINT on one page. Preview it with sample data, then open it live with a free account.

Preview the WINT dossier

Active events for WINT

  • mediumEarnings below estimates

    Q3-2023: Missed consensus by 33.8% - EPS $-43 vs $-32.13 estimate

  • mediumEarnings above estimates

    Q4-2023: Beat consensus by 22.8% - EPS $-37 vs $-47.94 estimate

  • mediumEarnings below estimates

    Q2-2024: Missed consensus by 152.8% - EPS $-1045.55 vs $-413.61 estimate

  • mediumEarnings below estimates

    Q3-2024: Missed consensus by 139.3% - EPS $-277 vs $-115.77 estimate

  • mediumEarnings below estimates

    Missed consensus by 33.8% - EPS $-43 vs $-32.13 estimate

FREE, NO ACCOUNT

Every event on WINT, as it fires

You are seeing 5 of 8 events recorded on WINT since 2026-06-01.

The five above landed across 2 days. The other 3 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, WINT

Related tickers

Follow WINT on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to WINT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the WINT dossier
Share

The WINT intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.